Moelis (MC) Q2 2026 earnings review
Record Revenues Confirm M&A Rebound, But Expense Creep Needs Watching
Moelis broke out of its Q1 deceleration, delivering a solid 12% YoY revenue increase to $409.4M in Q2. The top-line beat was driven by higher average fees per completed transaction, signaling that the M&A recovery is moving from lower-fee advisory into higher-value closed deals. Adjusted EPS grew 19% to $0.63, supported by a disciplined and stable compensation ratio. However, non-compensation expenses surged 26% YoY, driven by aggressive investments in AI technology, new London office space, and travel. While the balance sheet remains fortress-like with zero debt, management must ensure these heavy infrastructure and talent investments yield proportionate revenue growth in the second half of the year.
🐂 Bull Case
The 12% revenue growth was explicitly driven by higher average fees per transaction. This indicates Moelis is successfully closing larger mandates and moving past the initial advisory phase of the current M&A cycle.
Despite aggressive hiring, the compensation ratio held steady at 65.8%, a full 320 basis points lower than the 69.0% reported in Q2 of the prior year. This demonstrates management's ability to extract operating leverage as revenues recover.
🐻 Bear Case
Adjusted non-comp expenses jumped 26% YoY to $66.5M. Higher travel, new UK office build-outs, and significant AI investments pushed the non-comp ratio to 16.2%, eating into the margin gains from lower banker pay ratios.
With 12 new Managing Directors hired or committed in H1 2026, fixed costs are rising. If geopolitical headwinds or delayed rate cuts stall the M&A recovery, these expensive hires will severely compress margins.
⚖️ Verdict: 🟢
Bullish. The top-line re-acceleration and strict compensation discipline outweigh the non-compensation expense creep. The firm is actively building its future capacity, supported by a flawless balance sheet.
Key Themes
Transaction Fee Sizes Expanding
Accelerating. Following a Q1 where revenue grew only 4%, Q2 revenue growth accelerated to 12% ($409.4M). Management explicitly cited 'an increase in average fees earned per completed transaction' as the primary driver. This validates previous management claims that large-cap and transformational strategic deals are successfully making their way through the closing pipeline.
Aggressive Senior Talent Acquisition
Stable. Moelis is aggressively front-running the market recovery. The firm onboarded six Managing Directors year-to-date across Private Credit Secondaries, Securitization, Energy, and Healthcare IT, with six more committed to join later this year. This continued investment in human capital acts as the primary long-term revenue driver.
Non-Compensation Expense Creep
Accelerating. While management successfully contained compensation ratios, adjusted non-compensation expenses spiked 26% YoY to $66.5M. This pushed the non-comp margin to 16.2% (up from 14.4% a year ago). The culprits: new office space (London expansion), heightened deal travel, and investments in AI capabilities. This line item requires close monitoring to ensure fixed costs don't outpace revenue growth.
AI: A Dual Force of Disruption and Investment
AI remains a double-edged sword for the firm. On one hand, Moelis is heavily investing in AI infrastructure internally, driving up its 'communication and technology' expenses by 15% YoY in H1 2026. On the other hand, past management commentary warned that AI is causing severe dislocation and re-pricing in software M&A, making traditional tech deals 'harder in the near term' while creating potential future liability management opportunities.
Private Capital Advisory (PCA) Expansion
Accelerating. Moelis continues to bet heavily on its 'fourth pillar'. Among the 12 total MDs hired or committed for 2026, three are specifically targeted for the Private Capital Advisory segment. This GP-led secondaries business is ramping up exactly as the market faces a massive backlog of sponsor-held assets requiring monetization.
European M&A Rebound Lags
Stable. The firm is incurring duplicate occupancy expenses ($0.7M in Q2) to build out a larger UK office, yet previous quarters have highlighted that European M&A momentum trails the US due to structural and regulatory friction. Moelis is committing significant capital to a region that has yet to prove it can match North American transaction velocity.
Other KPIs
Stable sequentially vs 26Q1, but represents a massive 320 basis point improvement vs the 69.0% ratio in 25Q2. Maintaining this ratio despite adding 6 new MDs proves the firm is generating sufficient per-banker revenue to absorb expensive senior hires without diluting overall profitability.
Capital returned to shareholders in H1 2026, inclusive of $140.8M in share repurchases (2.3 million shares) and dividends. The balance sheet remains flawless with $481.1M in cash and short-term investments and zero debt, providing a massive buffer against unexpected market shocks.
Guidance
Accelerating. The firm has secured commitments from six additional Managing Directors to join throughout the remainder of the year (three in PCA, two in Europe Sponsors/Infrastructure, one in Capital Structure Advisory). This guarantees near-term pressure on base compensation but sets the stage for 2027 revenue growth.
Stable. The board maintained the regular quarterly dividend, payable in September, signaling ongoing confidence in forward cash flow generation despite rising infrastructure expenses.
Key Questions
Quantifying the AI Investment Return
Communication and technology expenses are rising materially due to internal AI investments. When does management expect these investments to translate into measurable operating leverage or a structural reduction in junior banker headcount?
Private Capital Advisory Revenue Mix
With three more MDs joining PCA this year, what percentage of total Q2 revenue was driven by this 'fourth pillar,' and is it currently accretive to the firm's 18.6% pre-tax margin?
Sponsor M&A Unblocking
You noted higher average fees per transaction. Are you finally seeing the broad-based middle-market sponsor exit environment fully unblock, or are these larger fees still concentrated in large-cap strategic deals?
London Expansion Timeline
Given the ongoing duplicate rent expenses for the new UK office, when exactly will the transition be complete, and what is the normalized run-rate for occupancy expenses moving forward?